Oppenheimer Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Oppenheimer Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,806	Closed	-$138K	–	1653
2019 Q1	$138K	Buy	8,806 +8,367	+1,906%	+$148K	﹤0.01%	1134
2018 Q4	$7K	Buy	+439	New	+$9K	﹤0.01%	1535
2018 Q1	–	Sell	-23,568	Closed	-$415K	–	1177
2017 Q4	$415K	Hold	23,568	–	–	0.01%	836
2017 Q3	$415K	Sell	23,568 -2,858	-11%	-$64.3K	0.01%	840
2017 Q2	$878K	Buy	26,426 +5,468	+26%	+$169K	0.02%	629
2017 Q1	$672K	Buy	+20,958	New	+$715K	0.02%	706

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Oppenheimer Asset Management's TEVA Position: Q2 2019 in Review

Oppenheimer Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 8,806 shares — an estimated $138K sold.

Oppenheimer Asset Management first reported a position in TEVA in Q1 2017 and held it in 6 quarters. The position peaked at $878K in Q2 2017. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Oppenheimer Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
Oppenheimer Asset Management sold 8,806 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $138K.
Oppenheimer Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2017 and held it in 6 quarters.
Oppenheimer Asset Management's Teva Pharmaceutical Industries Limited position peaked at $878K in Q2 2017.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Oppenheimer Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.